attB53-Pac-TRE-3xFlag-Neurog1-attB53
(Plasmid
#183613)
-
PurposeRMCE vector to shuttle puromycin resistance and TRE-3xFlag-Neurog1 cassettes into attP50-flanked landing pad. Designed for use with pmROSA26-attP50-Neo-mKate2-3xNLS-attP50 vector (Addgene 183609).
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 183613 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneattB53-Pac-TRE-mCherry-attB53 (Addgene 183611)
- Backbone size w/o insert (bp) 3830
- Total vector size (bp) 4667
-
Vector typeMammalian Expression ; RMCE
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameNeurog1
-
Alt nameNgn1
-
SpeciesM. musculus (mouse)
-
Insert Size (bp)837
-
GenBank IDNM_010896.3
-
Entrez GeneNeurog1 (a.k.a. AKA, Math4C, Neurod3, bHLHa6, ngn1)
- Promoter TRE
-
Tag
/ Fusion Protein
- 3xFlag (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NdeI (not destroyed)
- 3′ cloning site MfeI (not destroyed)
- 5′ sequencing primer CGTTTCCCGTTGAATATGGCTC
- 3′ sequencing primer GAAATTTGTGATGCTATTGC (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
attB53-Pac-TRE-3xFlag-Neurog1-attB53 was a gift from Sally Lowell (Addgene plasmid # 183613 ; http://n2t.net/addgene:183613 ; RRID:Addgene_183613) -
For your References section:
SyNPL: Synthetic notch pluripotent cell lines to monitor and manipulate cell interactions in vitro and in vivo. Malaguti M, Migueles RP, Annoh J, Sadurska D, Blin G, Lowell S. Development. 2022 May 26. pii: 275525. doi: 10.1242/dev.200226. 10.1242/dev.200226 PubMed 35616331